The Role of Regulatory B Lymphocytes in Allergic Diseases
Agnieszka Lipińska-Opałka,Michalina Leszczyńska-Pilich,Agata Będzichowska,Agata Tomaszewska,Agnieszka Rustecka,Bolesław Kalicki
DOI: https://doi.org/10.3390/biomedicines12122721
IF: 4.757
2024-11-28
Biomedicines
Abstract:Purpose of review: Regulatory B cells (Bregs) are a key component in the regulation of the immune system. Their immunosuppressive function, which includes limiting the inflammatory cascade, occurs through interactions with other immune cells and the secretion of cytokines, primarily IL-10. As knowledge about B cells continues to expand, their diversity is becoming more recognized, with many subpopulations identified in both human and animal models. However, identifying specific transcription factors or markers that could definitively distinguish regulatory B cells remains a challenge. This review summarizes recent findings on the role of B regulatory cells in allergic diseases. Recent findings: In patients with bronchial asthma, atopic dermatitis, and food allergies, the number of regulatory B cells is reduced, and disease severity is inversely proportional to the quantity of these cells. Furthermore, in patients with atopic dermatitis, the ability of regulatory B cells to produce IL-10 in response to IL-6 stimulation is diminished. However, allergen immunotherapy has been shown to induce the formation of regulatory T cells as well as regulatory B cells. Summary: The success of future therapies based on B cells may depend on deepening our current understanding of their phenotypes, induction, differentiation, and function. Research in these areas is essential for understanding the mechanisms regulating Breg activity and for developing potential targeted therapies in the treatment of allergic diseases.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy